[Patient-specific cost calculation--a good way to evaluate new therapeutic methods].
Westin
Jan
J
Institutionen för medicin, Universitetssjukhuset i Lund. jan.westin@med.lu.se
D000970:Antineoplastic Agents / Q000191:economics; D003362:Cost-Benefit Analysis / Q000379:methods; D016527:Drug Costs; D004358:Drug Therapy / Q000191:economics* / Q000379:methods; D017050:Episode of Care; D017048:Health Care Costs; D006801:Humans; D007938:Leukemia / Q000188:drug therapy / Q000191:economics; D009101:Multiple Myeloma / Q000188:drug therapy / Q000191:economics; D033581:Stem Cell Transplantation / Q000191:economics; D016896:Treatment Outcome
D000970:Antineoplastic Agents